Results 241 to 250 of about 420,702 (297)

Analytical Methods for Fluid Biomarkers in Alzheimer's Disease from Discovery to Clinical Implementation. [PDF]

Int J Mol Sci
Agnello L, Dominici R, Gambino CM, Scazzone C, Ciaccio M.   +4 more
europepmc   +1 more source

The Role of Calcitonin Gene‐Related Peptide in High‐Altitude Headache: A Prospective Field Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective High‐altitude headache (HAH) is a common neurological condition associated with rapid ascent to high altitude. The pathophysiological mechanisms underlying HAH remain incompletely understood. Calcitonin gene‐related peptide (CGRP), a neuropeptide implicated in migraine pathophysiology, may play a key role in the pathophysiology of ...
Roman Schniepp, Ludwig Karrasch, Helena Breitenstein, Andreas Straube, Katharina Kamm   +4 more
wiley   +1 more source

Metabolic, Cardiovascular, and Stress Biomarker Adaptations to Breath-Hold Training in a National-Level Swimmer: A Signal-Generating Single-Case Study. [PDF]

J Funct Morphol Kinesiol
D'Orsi G, Vasco P, Marzovillo RRR, Forte N, Scioscia G, Cartagena G, Marinaccio LA, Torquato ML, Cibelli G, Valenzano AA.   +9 more
europepmc   +1 more source

Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone, Freddy Chafota, Miguel E. Rentería, Randi J. Hagerman, Ellery Santos, Anna Atkinson, Nicholas G. Martin, Elsdon Storey, Danuta Z. Loesch   +8 more
wiley   +1 more source

An international consensus on core reproducibility items in research. [PDF]

PLoS Biol
Banzi R, Varga M, Gelsleichter YA, Vinatier C, Moher D, Naudet F, OSIRIS-Delphi Study Group.   +6 more
europepmc   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source

Blood-based biomarkers for Alzheimer's disease diagnosis: a joint position paper from the Italian Societies of Neurology (SIN) and of Clinical Biochemistry and Clinical Molecular Biology - Laboratory Medicine(SIBioC) and from the Autonomous Association affiliated with SIN for dementia (SINdem). [PDF]

Neurol Sci
Gaetani L, Agnello L, Pilotto A, Benussi A, Cagnin A, Parnetti L, Bozzali M, Padovani A, Ciaccio M, Italian Society of Neurology (SIN) Study Group on Biomarkers in Neurology, Italian Society of Clinical Biochemistry and Clinical Molecular Biology –Laboratory Medicine (SIBioC) Study Group on Neurological Markers.   +10 more
europepmc   +1 more source

Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and Survival

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To assess the association and discriminative performance of serum biomarkers with clinical disease progression and survival in patients with amyotrophic lateral sclerosis (ALS). Methods This retrospective study, conducted at Houston Methodist Hospital, Houston, TX, used longitudinal serum samples collected between January 2018 and ...
David R. Beers, Yueh‐Yun Lin, Jason R. Thonhoff, Aaron D. Thome, Alireza Faridar, Weihua Zhao, Shixiang Wen, Stanley H. Appel   +7 more
wiley   +1 more source

Carbon footprint of a clinical biochemistry platform in a French university hospital: Identifying the main greenhouse gas emission sources. [PDF]

J Clim Chang Health
Cécile K, Margaux V, Florence R, Chrystel L, Didier B, Camille CG.   +5 more
europepmc   +1 more source

Dynamic Precision Oncology for Real-Time Molecular Monitoring and Management in Urothelial Carcinoma. [PDF]

Int J Mol Sci
Kwon WA, Lee YJ, Song YS.
europepmc   +1 more source